These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24325170)

  • 21. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance characteristics of two automated solid-phase red cell adherence systems for pretransfusion antibody screening: a cautionary tale.
    Quillen K; Caron J; Murphy K
    Immunohematology; 2012; 28(4):137-9. PubMed ID: 23421544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of optimal method for antibody identification in a reference laboratory.
    Haywood JR; Moulds MK; Bryant BJ
    Immunohematology; 2011; 27(4):146-50. PubMed ID: 22646070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative sensitivity of solid phase versus PEG enhancement assays for detection and identification of RBC antibodies.
    Dwyre DM; Erickson Y; Heintz M; Elbert C; Strauss RG
    Transfus Apher Sci; 2006 Aug; 35(1):19-23. PubMed ID: 16905362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Positive direct antiglobulin test (DAGT) using the gel system].
    Frey-Wettstein M; Froelicher S
    Beitr Infusionsther; 1992; 30():378-81. PubMed ID: 1284739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The suitability of hemolyzed specimens for compatibility testing using automated technology.
    Laga A; Cheves T; Maroto S; Coutts M; Sweeney J
    Transfusion; 2008 Aug; 48(8):1713-20. PubMed ID: 18482191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Irregular antibodies. A comparative study of 2 series of 20,000 subjects: one with a conventional identification test, the other with gel-test].
    Trophilme C; Becker AM; Jaffard HP; Jaulin P
    Transfus Clin Biol; 1995; 2(3):189-99. PubMed ID: 7627358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased alloimmunisation and transfusion reaction reporting in patients with solid-phase panreactivity.
    Olofson AM; Chandler RM; Marx-Wood CR; Babcock CA; Dunbar NM
    J Clin Pathol; 2017 Nov; 70(11):981-983. PubMed ID: 28424235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial results of a prospective study with automated solid phase and column/agglutination techniques in screening for transfusion relevant IgG antibodies].
    Simson G; Lynen R; Bialek C; Kloppmann T; Bargmann I; Köhler M
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():52-7. PubMed ID: 8374290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Superiority of the gel centrifugation method (ID System) in detection of erythrocyte antibodies].
    Kretschmer V; Heuckeroth A; Schulzki T; Dietrich G
    Beitr Infusionsther; 1992; 30():375-7. PubMed ID: 1284738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell alloimmunisation in oncology patients: A study from eastern India.
    Dhar S; Basu S
    Transfus Apher Sci; 2015 Jun; 52(3):345-9. PubMed ID: 25818996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of irregular red cell antibodies: more than 3 years of experience with a gel technique and pooled screening cells.
    Titlestad K; Georgsen J; Andersen H; Kristensen T
    Vox Sang; 1997; 73(4):246-51. PubMed ID: 9407642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the structure and clinical significance of the positive results of pretransfusion testing during the switching from tube test agglutination to gel microcolumn technique].
    Petrusić-Kafedzić A; Ivanković Z; Ekinović S; Hutinović A; Ibrahimagić-Seper L
    Med Glas (Zenica); 2010 Aug; 7(2):124-31. PubMed ID: 21258307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of erythrocyte antibodies using solid phase assays].
    Beckmann-Emami E; Emami M; Kühnl P; Lliger C
    Beitr Infusionsther; 1990; 26():342-4. PubMed ID: 1703869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohematologic and patient safety benefits of a centralized transfusion database.
    Delaney M; Dinwiddie S; Nester TN; Aubuchon JA
    Transfusion; 2013 Apr; 53(4):771-6. PubMed ID: 22803792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red cell antibody screening, red cell antibody identification and compatibility testing with the Column Agglutination Technology (CAT). The Bio Vue system.
    Lamy B; Tissot C; Heyd C; Lamy C
    Transfus Clin Biol; 1994; 1(2):121-7. PubMed ID: 8019646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When should antibody screening tests be done for recently transfused patients?
    Shulman IA; Nelson JM; Nakayama R
    Transfusion; 1990 Jan; 30(1):39-41. PubMed ID: 2296788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R; Endert G; Lammel G
    Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application of microcolumn gel immunoassay in screening the platelet antibody].
    Xu DY; Dong GF; Zhang Z; Peng MX; Du Y; Chen CS; Tang XX; Fu JY; Gao JL; Bai J; Ma YL; Qian BY; Ma JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):888-91. PubMed ID: 17708827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.